| COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study T Chatzikonstantinou, A Kapetanakis, L Scarfò, G Karakatsoulis, D Allsup, ... Leukemia 35 (12), 3444-3454, 2021 | 76 | 2021 |
| Optical Genome Mapping: A promising new tool to assess genomic complexity in chronic lymphocytic leukemia (CLL) A Puiggros, S Ramos-Campoy, J Kamaso, M de la Rosa, M Salido, ... Cancers 14 (14), 3376, 2022 | 26 | 2022 |
| Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic … I Martín, E Villamón, R Abellán, MJ Calasanz, A Irigoyen, G Sanz, E Such, ... British Journal of Haematology 194 (4), 708-717, 2021 | 7 | 2021 |
| Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL D Antic, N Milic, T Chatzikonstantinou, L Scarfò, V Otasevic, N Rajovic, ... Journal of hematology & oncology 15 (1), 116, 2022 | 5 | 2022 |
| The evolving landscape of COVID‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL A Visentin, T Chatzikonstantinou, L Scarfò, A Kapetanakis, ... American journal of hematology 98 (12), 1856-1868, 2023 | 3 | 2023 |
| Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... EClinicalMedicine 65, 2023 | 1 | 2023 |
| Real-world evidence on therapeutic strategies and treatment-sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research … T Chatzikonstantinou, L Scarfo, C Demosthenous, J Kotaskova, ... Blood 138 (Supplement 1), 2635-2635, 2021 | 1 | 2021 |
| PB1911: CYTOGENOMIC INTEGRATIVE ANALYSIS OF CLL/SLL PATIENTS AT DISEASE PROGRESSION. R García-Serra, M Uribe, O Mompel, C Játiva, A Cámara, M Monzó, ... HemaSphere 7 (S3), e368931d, 2023 | | 2023 |
| S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY. T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... HemaSphere 7, e24596f8, 2023 | | 2023 |
| Pilot Inter-Laboratory Comparison Study of Optical Genome Mapping Analysis for Cytogenomic Characterization of Hematological Malignancies: A Spanish Multicentric Study A Puiggros, M Mallo, M Salido, A Gómez-García, A Cisneros, ... Blood 140 (Supplement 1), 4981-4983, 2022 | | 2022 |
| PB2084: FIRST-LINE TREATMENT IN ADVANCED STAGE FOLICULAR LYMPHOMA: A SINGLE-CENTER EXPERIENCE WITH R-CHOP VS BENDAMUSTINE-RITUXIMAB. O Mompel, C Amorós, P López-Menargues, C Játiva, A Cámara, ... HemaSphere 6, 1955-1956, 2022 | | 2022 |
| PB2070: EFFICACY OF RITUXIMAB MAINTENANCE THERAPY IN ADVANCED-STAGE FOLLICULAR LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY. C Amorós, O Mompel, P López-Menargues, C Játiva, A Cámara, ... HemaSphere 6, 1941-1942, 2022 | | 2022 |
| Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and COVID-19: A study of ERIC, the European Research Initiative on CLL D Antic, N Milic, T Chatzikonstantinou, L Scarfò, V Otasevic, N Rajovic, ... | | 2022 |
| Analysis of genomic complexity in patients with chronic lymphocytic leukemia (CLL) using optical genome mapping A Puiggros, S Ramos-Campoy, T Mantere, M Salido, C Melero, ... EUROPEAN JOURNAL OF HUMAN GENETICS 30 (SUPPL 1), 384-384, 2022 | | 2022 |
| EXPERIENCE WITH ELTROMBOPAG IN PATIENTS WITH MODERATE MEDULLARY APLASIA AND MYELODYSPLASIC HYPOPLASIC SYNDROMES M Olga, LM Patricia, U Marisol, J Cristina, GS Rocio, J Maria, ... HAEMATOLOGICA 106 (10), 248-248, 2021 | | 2021 |
| DIFFERENTIAL DIAGNOSIS BY FLOW CYTOMETRY BETWEEN MONOCLONAL B LYMPHOCYTOSIS AND CLL ACCORDING TO SCREENING TUBE COUNT VS. TUBE 2 OF B LYMPHOPROLIFERATIVE PATHOLOGIES U Barrientos Marisol, OC Maria Teresa, L Menargues Patricia, ... HAEMATOLOGICA 106 (10), 178-179, 2021 | | 2021 |
| MANTLE LYMPHOMA IN PATIENTS OVER 65 YEARS OLD NOT CANDIDATED FOR HPT, EXPERIENCE WITH FIRST-LINE TREATMENT: R-CHOP VERSUS R-BENDAMUSTINE BM Uribe, MJ Lis, P Lopez-Menargues, PO Mompel, CMT Orero, ... HAEMATOLOGICA 105, 302-303, 2020 | | 2020 |
| RESPONSE TO TREATMENT IN PATIENTS WITH CHRONIC LYMPHATIC LEUKEMIA AND COMPLEX KARYOTYPE BM Uribe, R Garcia-Serra, A Puiggros, S Ramos-Campoy, ... HAEMATOLOGICA 105, 177-178, 2020 | | 2020 |
| CYTOGENETIC CHARACTERIZATION OF PROGNOSTIC RISK GROUPS ACCORDING TO THE IPS-E INDEX IN PATIENTS WITH EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA R Garcia-Serra, M Uribe, P Lopez-Menargues, O Mompel, MJ Lis, ... HAEMATOLOGICA 105, 65-66, 2020 | | 2020 |
| PROGNOSTIC IMPACT OF THE NEUTROPHILE/LYMPHOCYTE RATIO IN PATIENTS WITH MULTIPLE MYELOMA AT DIAGNOSIS O Mompel, BM Uribe, P Lopez-Menargues, MT Orero, M Roig, PL Perez, ... HAEMATOLOGICA 105, 139-139, 2020 | | 2020 |
